CYTOX
Cytox have developed a simple genetic based blood test for the assessment of risk and diagnosis of Alzheimer's Disease in the very early stages. Alzheimer's Disease affects over 26 million people world-wide and is a growing condition as people live longer. There is currently no cure for Alzheimer's Disease, but there are large international initiatives underway to find treatments with many drugs in clinical development. Cytox are commercially launching their tests in conjunction with Affymetrix (part of Thermo Fisher Scientific) to support Pharmaceutical and Biotechnology companies developing novel therapeutics.
CYTOX
Industry:
Biotechnology Genetics
Founded:
2004-01-01
Address:
Manchester, Manchester, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cytoxgroup.com
Total Employee:
1+
Status:
Active
Contact:
+441212024778
Email Addresses:
[email protected]
Total Funding:
15.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Google Universal Analytics Font Awesome Global Site Tag Nginx Google Maps
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Cytox
GM&C Life Sciences Fund
GM&C Life Sciences Fund investment in Series B - Cytox
Future Planet Capital
Future Planet Capital investment in Series B - Cytox
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Series B - Cytox
Perivoli Innovations
Perivoli Innovations investment in Series B - Cytox
Nesta Ventures
Nesta Ventures investment in Series B - Cytox
Seneca Partners
Seneca Partners investment in Series A - Cytox
Wren Capital
Wren Capital investment in Series A - Cytox
Future Planet Capital
Future Planet Capital investment in Series A - Cytox
Midven
Midven investment in Series A - Cytox
Official Site Inspections
http://www.cytoxgroup.com Semrush global rank: 6.61 M Semrush visits lastest month: 927
- Host name: 172.67.130.129
- IP address: 172.67.130.129
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
